BlueCrest Capital Management’s Chemed CHE Stock Holding History

BlueCrest Capital Management’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,264	Closed	-$405K	–	511
2019 Q1	$405K	Buy	+1,264	New	+$388K	0.02%	567
2018 Q4	–	Sell	-15,048	Closed	-$4.81M	–	936
2018 Q3	$4.81M	Sell	15,048 -27,283	-64%	-$8.69M	0.13%	112
2018 Q2	$13.6M	Buy	42,331 +41,463	+4,777%	+$13M	0.35%	47
2018 Q1	$237K	Buy	+868	New	+$230K	0.01%	1195
2016 Q3	–	Sell	-5,563	Closed	-$758K	–	771
2016 Q2	$758K	Buy	5,563 +3,843	+223%	+$510K	0.03%	418
2016 Q1	$233K	Buy	+1,720	New	+$232K	0.01%	644
2015 Q4	–	Sell	-2,012	Closed	-$269K	–	990
2015 Q3	$269K	Buy	+2,012	New	+$282K	0.01%	728

Other funds holding CHE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

BlueCrest Capital Management's CHE Position: Q2 2019 in Review

BlueCrest Capital Management sold out of Chemed (CHE) in Q2 2019, closing a stake of 1,264 shares — an estimated $405K sold.

BlueCrest Capital Management first reported a position in CHE in Q3 2015 and held it in 7 quarters. The position peaked at $13.6M in Q2 2018. 370 funds tracked by Wall St. Rank hold CHE as of Q2 2019.

BlueCrest Capital Management reported no remaining Chemed position as of Q2 2019 after selling out during the quarter.
BlueCrest Capital Management sold 1,264 Chemed shares in Q2 2019, an estimated $405K.
BlueCrest Capital Management first reported a position in Chemed in Q3 2015 and held it in 7 quarters.
BlueCrest Capital Management's Chemed position peaked at $13.6M in Q2 2018.
370 funds tracked by Wall St. Rank held Chemed as of Q2 2019.

Based on BlueCrest Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.